Citations

Clear

6274 citation(s) found for "To, Andrew".

Chronic Histologic Changes Are Present Regardless of HLA Mismatches: Evidence from HLA-Identical Living Donor Kidney Transplants
D’Costa, Matthew R. , Bentall, Andrew , Đenić, Aleksandar , Merzkani, Massini , Ryan, Margaret , Alexander, Mariam P., Gandhi, Manish J. , Ryan, Margaret S, D'Costa, Matthew , Denic, Aleksandar , Bentall, Andrew , Schinstock, Carrie A. , Park, Walter D. , Smith, Byron H. , Stegall, Mark D.

Mayo Clinic

Transplantation | December 14, 2020 | Volume: 105 | Issue: 11 | Pages: e244-e256

10.1097/tp.0000000000003579 | PMID 33315759 Get It

Background. At 5 and 10 y after kidney transplantation, chronic histologic changes such as arteriolar hyalinosis and mesangial expansion are common; however, determining cause is difficult. We compared surveillance biopsies in living donor kidney transplants (LDKTx) from HLA-matched siblings (termed HLA-identical [HLA-ID]) with HLA non-ID to investigate which histologic changes were likely due to alloimmune injury and which were due to nonalloimmune injury. Methods. We performed a retrospective, cohort study comparing HLA-ID sibling LDKTx (n = 175) with HLA non-ID LDKTx (n = 175; matched for age, sex, and year of transplant ±2 y) performed at a single institution from March 1999 to November 2018. Results. Baseline characteristics and maintenance immunosuppression were similar. Mortality rates were similar, but in the HLA-ID group, 10-y death-censored graft survival was higher (93.8% versus 80.9% HLA non-ID LDKTx; P < 0.001), rejection rates were lower (after 1 y 9.6% versus 27.1%; P < 0.001), and Banff inflammation scores including glomerulitis and peritubular capillaritis were lower on surveillance biopsies at 1, 5, and 10 y. In contrast, chronic Banff scores (interstitial fibrosis, arteriolar hyalinosis, mesangial expansion, etc) were similar in prevalence and severity on surveillance biopsies at 1, 5, and 10 y. Conclusions. HLA-ID LDKTx have less inflammation and less transplant glomerulopathy, but most chronic histologic changes were similar to less well-matched LDKTx. We conclude that these types of chronic changes are not associated with HLA mismatches and may be due to nonimmunologic causes (hypertension, obesity, etc), suggesting that new management approaches to prevent these lesions may be needed.
Comparison of Two-level Cervical Disc Replacement Versus Two-level Anterior Cervical Discectomy and Fusion in the Outpatient Setting
Makovicka, Justin L. , Polveroni, Thomas M. , Doan, Matthew K. , Hassebrock, Jeffrey D. , Chung, Andrew S. , Patel, Karan A.

Mayo Clinic

Spine | December 14, 2020 | Volume: 46 | Issue: 10 | Pages: 658-664

10.1097/brs.0000000000003871 | PMID 33315775 Get It

Study Design. Retrospective cohort study. Objective. The aim of this study was to evaluate the safety of two-level cervical disc replacement (CDR) in the outpatient setting. Summary of Background Data. Despite growing interest in CDR, limited data exist evaluating the safety of two-level CDR in the outpatient setting. Methods. The National Surgical Quality Improvement Program (NSQIP) database was queried for all two-level anterior cervical discectomy and fusion (ACDF) and CDR procedures between 2015 and 2018. Demographics, comorbidities, and 30-day postoperative complication rates of outpatient two-level CDR were compared to those of inpatient two-level CDR and outpatient two-level ACDF. Radiographic data are not available in the NSQIP. Results. A total of 403 outpatient CDRs were compared to 408 inpatient CDRs and 4134 outpatient ACDFs. Outpatient CDR patients were older and more likely to have pulmonary comorbidities compared to inpatient CDR (P < 0.03). Outpatient CDR patients were less likely to have an American Society of Anesthesiologists class ≥2 and have hypertension compared to outpatient ACDF patients (P < 0.0001). Outpatient CDR had a lower 30-day readmission rate (0.5% vs. 2.5%, P = 0.02) and lower 30-day reoperation rate (0% vs. 1%, P = 0.047) compared to inpatient CDR. Outpatient CDR had a lower readmission rate (0.5% vs. 2.1%, P = 0.03) compared to outpatient ACDF, but there was no difference in reoperation rates between the two procedures (0% vs. 0.8%, P = 0.07). Outpatient CDR had an overall complication rate of 0.2%, inpatient CDR had a complication rate of 0.9%, and outpatient ACDF had a complication rate of 1.3%. These differences were not significant. Conclusion. To our knowledge, this is the largest multicenter study examining the safety of two-level outpatient CDR procedures. Outpatient two-level CDR was associated with similarly safe outcomes when compared to inpatient two-level CDR and outpatient two-level ACDF. This suggests that two-level CDR can be performed safely in the outpatient setting. Level of Evidence: 3
Cigarette smoking enhances the metabolic activation of the polycyclic aromatic hydrocarbon phenanthrene in humans
Luo, Kai , Luo, Xianghua , Cao, Wenhao , Hochalter, J. Bradley, Paiano, Viviana, Sipe, Christopher J. , Carmella, Steven G. , Murphy, Sharon E. , Jensen, Joni , Lam, Stephen , Golin, Andrew P. , Bergstrom, Lori , Midthun, David E. , Fujioka, Naomi , Midthun, David, Cao, Wenhao, Hatsukami, Dorothy K. , Hecht, Stephen S.

Mayo Clinic

Carcinogenesis | December 11, 2020 | Volume: 42 | Issue: 4 | Pages: 570-577

10.1093/carcin/bgaa137 | PMID 33319219 Get It

AbstractAlthough it is well established that human cytochrome P450 1 family enzymes are induced by cigarette smoking through activation of the Ah receptor, it is not known whether this leads to increased metabolic activation or detoxification of carcinogenic polycyclic aromatic hydrocarbons (PAH), which are present in cigarette smoke and the general environment. We gave oral doses of deuterated phenanthrene ([D10]Phe), a non-carcinogenic surrogate of carcinogenic PAH such as benzo[a]pyrene, to smokers (N = 170, 1 or 10 μg doses) and non-smokers (N = 57, 1 μg dose). Bioactivation products (dihydrodiol and tetraol) and detoxification products (phenols) of [D10]Phe were determined in 6-h urine to obtain a comprehensive metabolic profile. Cigarette smoking increased the bioactivation of [D10]Phe and decreased its detoxification resulting in significantly different metabolic patterns between smokers and non-smokers (P &lt; 0.01), consistent with increased cancer risk in smokers. The Phe bioactivation ratios ([D10]PheT/total [D9]OHPhe) were significantly higher (2.3 (P &lt; 0.01) to 4.8 (P &lt; 0.001) fold) in smokers than non-smokers. With solid human in vivo evidence, our results for the first time demonstrate that cigarette smoking enhances the metabolic activation of Phe, structurally representative of carcinogenic PAH, in humans, strongly supporting their causal role in cancers caused by smoking. The results suggest potential new methods for identifying smokers who could be at particularly high risk for cancer.
Implications of Peripheral Oedema in Heart Failure with Preserved Ejection Fraction: A Heart Failure Network Analysis
Fudim, Marat , Ashur, Nicolas, Jones, Aaron D. , Ambrosy, Andrew P. , Bart, Bradley A. , Chen, Horng H. , Greene, Stephen J. , Reddy, Yogesh N.V. , Redfield, Margaret M. , Sharma, Abhinav , Felker, G. Michael , Mentz, Robert J. , Reddy, Yogesh, Nishimura, Rick , Mentz, Robert J , Butler, Javed , Hernandez, Adrian F. , Borlaug, Barry A.

Mayo Clinic

ESC Heart Failure | December 10, 2020 | Volume: 8 | Issue: 1 | Pages: 662-669

10.1002/ehf2.13159 | PMID 33300277 Get It

Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous condition, and tissue congestion manifested by oedema is not present in all patients. We compared clinical characteristics, exercise capacity, and outcomes in patients with HFpEF with and without oedema. Methods and results This study was a post hoc analysis of pooled data of patients with left ventricular ejection fraction of ≥50% enrolled in the DOSE, CARRESS-HF, RELAX, ATHENA, ROSE, INDIE, and NEAT trials. Patients were dichotomized by the severity of oedema. Cox proportional hazard regression and generalized linear regression models were used to assess associations between oedema, symptoms, and clinical outcomes. The ambulatory cohort included 393 patients (228 with and 165 without oedema), and the hospitalized cohort included 338 patients (249 with ≥moderate oedema and 89 with mild or none). Among ambulatory patients, patients with oedema had a higher body mass index (35.2 kg/m2 [inter-quartile range, IQR 30.5, 41.6] vs. 31.6 kg/m2 [IQR 27.9, 36.3], P &lt; 0.001), greater burden of co-morbidities, higher intravascular pressures estimated on physical examination (elevated jugular venous pressure: 50% vs. 24.7%, P &lt; 0.001), poorer renal function (creatinine: 1.2 mg/dL [IQR 0.9, 1.5] vs. 1 mg/dL [IQR 0.8, 1.3], P = 0.003), and lower peak VO2 (adjusted mean difference −1.04 mL/kg/min, 95% confidence interval [−1.71, −0.37], P &lt; 0.003). Among hospitalized patients, despite greater in-hospital fluid/weight loss in the ≥moderate oedema group, there was no difference in the improvement in dyspnoea by the visual analogue scale or well-being visual analogue scale from baseline to 3–4 days and no statistically significant difference in the rate of 60 day rehospitalization/death (adjusted hazard ratio 1.44, 95% confidence interval [0.87, 2.39], P = 0.156). Conclusions Patients with HFpEF and oedema display higher body mass, greater burden of co-morbidities, and more severe exercise intolerance, but clinical responses to treatment appear similar. Further research is required to better understand the nature of volume distribution in different HFpEF phenotypes.
Esophagopericardial Fistula Causing Pyopneumopericardium
Bowman, Andrew W. , DiSantis, David J. , Frey, R , Frey, R Terrell , Bowman, Andrew W

Mayo Clinic

Radiology: Cardiothoracic Imaging | December 10, 2020 | Volume: 2 | Issue: 6 | Pages: e200417

10.1148/ryct.2020200417 | PMID 33778644 Get It

Management of the Incidental Liver Lesion
Yataco, Maria, Yataco, Maria L, Bowman, Andrew W. , Keaveny, Andrew P.

Mayo Clinic

American Journal of Gastroenterology | December 10, 2020 | Volume: 116 | Issue: 5 | Pages: 855-861

10.14309/ajg.0000000000001089 | PMID 33298700 Get It

7T MR Thermometry technique for validation of system‐predicted SAR with a home‐built radiofrequency wrist coil
Fagan, Andrew , Jacobs, Paul , Hulshizer, Thomas C., Rossman, Phillip J. , Frick, Matthew A., Amrami, Kimberly K. , Felmlee, Joel P. , Jacobs, Paul S, Fagan, Andrew J

Mayo Clinic

Medical Physics | December 10, 2020 | Volume: 48 | Issue: 2 | Pages: 781-790

10.1002/mp.14641 | PMID 33294999 Get It

PurposeA 7T magnetic resonance thermometry (MRT) technique was developed to validate the conversion factor between the system‐measured transmitted radiofrequency (RF) power into a home‐built RF wrist coil with the system‐predicted SAR value. The conversion factor for a new RF coil developed for ultra high magnetic field MRI systems is used to ensure that regulatory limits on RF energy deposition in tissue, specifically the local 10g‐averaged specific absorption rate (SAR10g), are not exceeded. MRT can be used to validate this factor by ensuring that MRT‐measured SAR values do not exceed those predicted by the system.MethodsA 14‐cm diameter high‐pass birdcage RF coil was built to image the wrist at 7T. A high spatial and temporal resolution dual‐echo gradient echo MRT technique, incorporating quasi‐simultaneous RF‐induced heating and temperature change measurements using the proton resonance frequency method, was developed. The technique allowed for high‐temperature resolution measurements (~±0.1°C) to be performed every 20 s over a 4‐min heating period, with high spatial resolution (2.56 mm3 voxel size) and avoiding phase discontinuities arising from severe magnetic susceptibility‐induced B0 inhomogeneities. Magnetic resonance thermometry was performed on a phantom made from polyvinylpyrrolidone to mimic the dielectric properties of muscle tissue at 297.2 MHz. Temperature changes measured with MRT and four fiber optic temperature sensors embedded in the phantom were compared. Electromagnetic simulations of the coil and phantom were developed and validated via comparison of simulated and measured B1+ maps in the phantom. The position of maximum SAR within the coil was determined from simulations, and MRT was performed within a wrist‐sized piece of meat positioned at that SAR hotspot location. MRT‐measured and system‐predicted SAR values for the phantom and meat were compared.ResultsTemperature change measurements from MRT matched closely to those from the fiber optic temperature sensors. The simulations were validated via close correlation between the simulated and MRT‐measured B1+ and SAR maps. Using a coil conversion factor of 2 kg−1, MRT‐measured point‐SAR values did not exceed the system‐predicted SAR10g in either the uniform phantom or in the piece of meat mimicking the wrist located at the SAR hotspot location.ConclusionsA highly accurate MRT technique with high spatial and temporal resolution was developed. This technique can be used to ensure that system‐predicted SAR values are not exceeded in practice, thereby providing independent validation of SAR levels delivered by a newly built RF wrist coil. The MRT technique is readily generalizable to perform safety evaluations for other RF coils at 7T.
Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?
Behr, Elijah R. , Ben‐Haim, Yael , Ackerman, Michael J. , Wilde, Arthur A.M. , Behr, Elijah Raphael , Krahn, Andrew D.

Mayo Clinic

European Heart Journal | December 10, 2020 | Volume: 42 | Issue: 11 | Pages: 1073-1081

10.1093/eurheartj/ehaa1051 | PMID 33421051 Get It

Abstract Brugada syndrome (BrS) was first described as a primary electrical disorder predisposing to the risk of sudden cardiac death and characterized by right precordial lead ST elevation. Early description of right ventricular structural abnormalities and of right ventricular outflow tract (RVOT) conduction delay in BrS patients set the stage for the current controversy over the pathophysiology underlying the syndrome: channelopathy or cardiomyopathy; repolarization or depolarization. This review examines the current understanding of the BrS substrate, its genetic and non-genetic basis, theories of pathophysiology, and the clinical implications thereof. We propose that the final common pathway for BrS could be viewed as a disease of ‘reduced RVOT conduction reserve’.
Per-pass analysis of acute ischemic stroke clots: impact of stroke etiology on extracted clot area and histological composition
Fitzgerald, Seán , Rossi, Rosanna , Mereuta, Oana Madalina , Jabrah, Duaa , Okolo, Adaobi , Douglas, Andrew , Gil, Sara M. , Pandit, Abhay , McCarthy, Ray, Gilvarry, Michael , Dunker, Dennis, Nordanstig, Annika , Ceder, Erik , Redfors, Petra , Dehlfors, Niclas, Magoufis, Georgios , Brinjikji, Waleed , Kallmes, David F. , O’Hare, Alan , Power, Sarah , Brennan, Paul , Alderson, Jack , Nagy, András , Vadász, Ágnes , Szikora, István , Rentzos, Alexandros , Thornton, John , Doyle, Karen , Brinjikji, Waleed , Szikora, Istvan , Doyle, Karen M , Fitzgerald, Seán , Madalina Mereuta, Oana , Rossi, Rosanna , Jood, Katarina , Tsivgoulis, Georgios , Psychogios, Klearchos , Tatlisumak, Turgut

Mayo Clinic

Journal of NeuroInterventional Surgery | December 9, 2020 | Volume: 13 | Issue: 12 | Pages: 1111-1116

10.1136/neurintsurg-2020-016966 | PMID 33298510 Get It

Background Initial studies investigating correlations between stroke etiology and clot composition are conflicting and do not account for clot size as determined by area. Radiological studies have shown that cardioembolic strokes are associated with shorter clot lengths and lower clot burden than non-cardioembolic clots. Objective To report the relationship between stroke etiology, extracted clot area, and histological composition at each procedural pass. Methods As part of the multi-institutional RESTORE Registry, the Martius Scarlett Blue stained histological composition and extracted clot area of 612 per-pass clots retrieved from 441 patients during mechanical thrombectomy procedures were quantified. Correlations with clinical and procedural details were investigated. Results Clot composition varied significantly with procedural passes; clots retrieved in earlier passes had higher red blood cell content (H4=11.644, p=0.020) and larger extracted clot area (H4=10.730, p=0.030). Later passes were associated with significantly higher fibrin (H4=12.935, p=0.012) and platelets/other (H4=15.977, p=0.003) content and smaller extracted clot area. Large artery atherosclerotic (LAA) clots were significantly larger in the extracted clot area and more red blood cell-rich than other etiologies in passes 1–3. Cardioembolic and cryptogenic clots had similar histological composition and extracted clot area across all procedural passes. Conclusion LAA clots are larger and associated with a large red blood cell-rich extracted clot area, suggesting soft thrombus material. Cardioembolic clots are smaller in the extracted clot area, consistent in composition and area across passes, and have higher fibrin and platelets/other content than LAA clots, making them stiffer clots. The per-pass histological composition and extracted clot area of cryptogenic clots are similar to those of cardioembolic clots, suggesting similar formation mechanisms.
Neoadjuvant Radiation Lobectomy and Immunotherapy for Angioinvasive HCC Resulting in Complete Pathologic Response
Liou, Harris , Mody, Kabir , Boyle, Ashton W., Croome, Kristopher P. , Burns, Justin M. , Harnois, Denise M. , Patel, Tushar , Toskich, Beau , Patel, Tushar , Croome, Kris P , Boyle, Ashton W.R. , Keaveny, Andrew P.

Mayo Clinic

Hepatology | December 8, 2020 | Volume: 74 | Issue: 1 | Pages: 525-527

10.1002/hep.31675 | PMID 33615518 Get It